跳至主要内容
临床试验/NCT06158035
NCT06158035尚未招募不适用

ED90 of Norepinephrine and Phenylephrine Boluses for Treating Postspinal Anesthesia Hypotension Under Intensive Treatment in Preeclamptic Patients During Cesarean Section

General Hospital of Ningxia Medical University0 个研究点目标入组 80 人开始时间: 2025年7月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
80
主要终点
ED50 and ED90

研究概览

简要总结

The objective of this study is to investigate the ED90 of norepinephrine and phenylephrine boluses for treating postspinal anesthesia hypotension under intensive treatment in preeclamptic patients during cesarean section

详细描述

Post-spinal anesthesia hypotension is a frequent complication during spinal anesthesia for cesarean section. The incidence of post-spinal anesthesia hypotension is as high as 62.1-89.7% if prophylactic measures are not taken. The 2016 ASA guidelines for obstetric anesthesia suggest avoiding hypotension following spinal anesthesia in women and emphasize the use of vasopressors, specifically alpha-receptor agonists, as the preferred strategy to prevent and manage post-spinal anesthesia hypotension. The 2018 International Consensus in the United Kingdom and Northern Ireland recommends maintaining maternal systolic blood pressure above 90% of the baseline value following lumbar anesthesia, while avoiding dropping below 80% of the baseline value. Currently, the threshold for maintaining blood pressure above 80% of the baseline value is widely adopted as a standard; however, limited evidence supports the advantage of sustaining maternal blood pressure above 90% of the baseline value. The objective of this study is to investigate the ED90 of norepinephrine and phenylephrine boluses for treating postspinal anesthesia hypotension under intensive treatment in preeclamptic patients during cesarean section

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Care Provider)

入排标准

年龄范围
18 Years 至 45 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • 18-45 years
  • Primipara or multipara
  • Singleton pregnancy ≥32 weeks
  • American Society of Anesthesiologists physical status classification I to III
  • Scheduled for cesarean section under spinal anesthesia

排除标准

  • Baseline blood pressure ≥160 mmHg
  • Body height < 150 cm
  • Body weight > 100 kg or body mass index (BMI) ≥ 40 kg/m2
  • Eclampsia or chronic hypertension
  • Hemoglobin < 7g/dl
  • Fetal distress, or known fetal developmental anomaly

研究组 & 干预措施

Phenylephrine group

Experimental

The maternal systolic blood pressure was consistently maintained above 90% of the preoperative baseline value from the initiation of spinal anesthesia until fetal delivery.

干预措施: Phenylephrine (Drug)

Norepinephrine group

Experimental

The maternal systolic blood pressure was consistently maintained above 90% of the preoperative baseline value from the initiation of spinal anesthesia until fetal delivery.

干预措施: Norepinephrine (Drug)

结局指标

主要结局

ED50 and ED90

时间窗: 1-15 minutes after spinal anesthesia

The doses of prophylactic norepinephrine and phenylephrine that would be effective in preventing postspinal anesthesia hypotension in 50% (effective dose, ED 50) and 90% (ED90) of patients

次要结局

  • Partial pressure of oxygen (PO2)(Immediately after delivery)
  • APGAR score(5 min after delivery)
  • The incidence of hypertension.(1-15 minutes after spinal anesthesia)
  • pH(Immediately after delivery)
  • Base excess(Immediately after delivery)
  • The incidence of bradycardia.(1-15 minutes after spinal anesthesia)
  • The incidence of post-spinal anesthesia hypotension(1-15 minutes after spinal anesthesia)
  • The incidence of severe post-spinal anesthesia hypotension.(1-15 minutes after spinal anesthesia)
  • The incidence of nausea and vomiting.(1-15 minutes after spinal anesthesia)

研究者

发起方
General Hospital of Ningxia Medical University
申办方类型
Other
责任方
Sponsor

相似试验

ED90 of Norepinephrine and Phenylephrine Boluses... | 临床试验